Try our mobile app

General information

Country: CANADA

Sector: Drug Manufacturers — Specialty and Generic

Categories: @cannabis-players   

Canopy Growth Corporation, through its subsidiaries, is a producer of medical marijuana. The Company`s group of brands represents distinct voices and market positions designed to appeal to an array of customers, doctors and strategic industry partners.
  • Current market environment: positive. Prices of production are 2.8% higher compared to the last 12 months (LTM)
  • Prices of production are at 29.7% percentile over the past 5 years, adjusted for inflation
  • Dividend yield for the last twelve months 0.0%
  • Free cash flow yield 1.0% (LTM), projected 0.4%
  • Share price is 2 454.2% higher than minimum and 70.2% lower than maximum for the last 3 years
  • The company is undervalued by EV / LTM EBITDA multiple compared to target level (-1.9x vs
    )
  • The company is undervalued by EV / projected EBITDA multiple compared to target level (
    vs
    )

Key Financials (Download financials)

Ticker: CGC
Share price, USD:  (+32.1%)9.55
year average price 1.74  


year start price 1.76 2023-03-30

min close price 0.37 2023-07-17

max close price 9.55 2024-03-27

current price 9.55 2024-03-28
Common stocks: 550 459 365

Dividend Yield:  0.0%
FCF Yield LTM / expected: 1.0% / 0.4%
EV / LTM EBITDA: -1.9x
Production prices change from LTM: 2.8%
EV / projected EBITDA:
Target EV / EBITDA (hist percentile):
Express share price potential:
EV / LTM EBITDA mutiple calculation
Market Cap ($m): 5 257
Net Debt ($m): 426
EV (Enterprise Value): 5 683
EBITDA LTM ($m): -2 928
EV / LTM EBITDA: -1.9x
Price to Book: 12.6x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / LTM EBITDA and 75% percentile

Potential dynamics

News


2024-03-27The Motley Fool

Why Marijuana and CBD Stocks Were Buzzing Today

2024-03-27Market Watch

Canopy Growth rally continues with 28% gain after recent talk about federal cannabis reforms

2024-03-26Schaeffers Research

2 Cannabis Stocks to Watch Amid Germany Legalization

2024-03-26The Motley Fool

Why Marijuana Stocks Are Hopping Again on Tuesday

2024-03-26InvestorPlace

3 Cannabis Stocks That Could Be Multibaggers in the Making: March Edition

2024-03-26MarijuanaStocks

Top Picks: Canadian Cannabis Giants Set to Flourish in Q2 2024

2024-03-25The Motley Fool

Why Canopy Growth Stock Dropped 9.5% Today

2024-03-25InvestorPlace

Cannabis Stocks CGC, ACB, TLRY, SNDL Already Fading Despite German Legalization

2024-03-25Invezz

Canopy Growth: CGC stock in focus as cannabis decriminalization talks gain momentum

2024-03-24MarijuanaStocks

The Marijuana Stocks Could See A Rise This Week
More information for subscribed users:
detailed calculation of Potential,
commodities and currency affecting the company